what is glp 1 agonist drugs GLP-1 receptor agonists review and effects Table 3 from Glucagon-Like Peptide-1

Philip Pape: 3:28 Now let's build our mental muscle by getting into today's topic

He managed to identify several new peptides and hormones, which he continued to investigate when he established a small laboratory at State University of New York Downstate Medical Center in Brooklyn

[97] observed a potential association between semaglutide and NAION, with incidence rates of 4.28 and 7.64 per 1,000 person-years in patients with T2DM and those who were overweight or obese, respectively, over 36 months

In the study, participants with a responsive genetic score had an 82% increase in the likelihood of acheiving weight loss with a GLP-1 medication.[ref] Another study showed that GLP1 receptor variants are associated with greater weight loss on GLP-1 RA drugs.[ref] Common genetic variants in the GLP1R (GLP-1 receptor) gene impact weight and type 2 diabetes risk

At present, semaglutide holds the maximum share of the GLP-1 market

Its also important to note that the long-term side effects of these drugs are not yet well-studied, Yuan said